Nova Leap Health Corp. Posts Record Q2 2025 Results

Core Viewpoint - Nova Leap Health Corp. reported record financial results for Q2 2025, highlighting significant growth in revenues, gross margins, and Adjusted EBITDA, indicating strong operational performance and effective business strategies [2][4][7]. Financial Performance - Q2 2025 revenues reached $8,021,072, marking a 13.1% increase from Q1 2025 and a 26.5% increase from Q2 2024 [2]. - Adjusted EBITDA for Q2 2025 was $577,907, a 99.9% increase from Q1 2025 and a 41.7% increase from Q2 2024 [4]. - Gross profit margin was 40.2% in Q2 2025, up from 39.0% in Q1 2025 and 38.4% in Q2 2024 [10]. Operational Highlights - The company achieved record consolidated quarterly revenues, gross margins, and Adjusted EBITDA across both Canadian and U.S. operating segments [5]. - The acquisition of a home care business in Nova Scotia for CAD$390,000 was completed in May 2025, contributing to the company's growth [10]. - Insider ownership increased to 42.26%, reflecting management's confidence in the company's future [11]. Strategic Initiatives - The company is focused on building a tech-enabled organization that leverages AI and fintech to enhance productivity [9]. - Operating leverage is evident, with Adjusted EBITDA margin expanding to 7.2% from 4.1% in Q1 2025, showcasing improved returns from scale and operational discipline [8]. Market Position - Nova Leap operates in a rapidly growing home health care industry, with a focus on individual and family-centered care, particularly for dementia patients [12]. - The company is geographically diversified, with operations in 10 U.S. states and Nova Scotia, Canada [12].